Learning that spinal muscular atrophy is linked to genetics often raises more questions than answers. Many families immediately wonder whether it was inherited, whether future children could also be affected, and why the condition develops in the first place. Understanding the cause is often the first step toward making informed decisions.
Many parents first hear about spinal muscular atrophy (SMA) after a newborn screening result, a delayed developmental milestone, or a family member receives a diagnosis. At that moment, one question usually rises above all the others: Why did this happen? Understanding the cause of SMA can help replace uncertainty with clarity. It also provides important context for conversations about genetic testing, family planning, and future care. While the condition itself can feel overwhelming, the science behind why SMA occurs is more straightforward than many people expect.
Spinal muscular atrophy is primarily caused by a change in a gene called SMN1. This gene provides instructions for making the Survival Motor Neuron (SMN) protein, which helps keep motor neurons healthy. Motor neurons are nerve cells that carry signals from the brain and spinal cord to the muscles, allowing movements such as crawling, walking, swallowing, and breathing.
When both copies of the SMN1 gene are missing or do not function properly, the body produces too little SMN protein. Without enough of this protein, motor neurons gradually become damaged and die. As these nerve cells are lost, muscles receive fewer signals, leading to progressive muscle weakness and reduced movement over time.
Although the condition affects muscles, the root cause begins in the body's genetic instructions rather than the muscles themselves.
The SMN1 gene acts like an instruction manual for producing the SMN protein. Most people inherit two working copies—one from each parent—which provide enough protein to keep motor neurons functioning normally.
When both inherited copies contain disease-causing mutations or deletions, protein production falls dramatically. As a result, motor neurons cannot maintain their normal function, leading to the symptoms associated with SMA.
Researchers have also identified another gene called SMN2. While it cannot fully replace SMN1, it produces a small amount of working SMN protein. The number of SMN2 copies varies from person to person, which is one reason why symptoms can differ between individuals with SMA.
Hidden Insight: Two people may have the same genetic condition but experience different levels of severity because their bodies produce different amounts of backup SMN protein through the SMN2 gene.
Yes. In the vast majority of cases, spinal muscular atrophy is a genetic disorder passed from parents to their children.
Unlike illnesses caused by infections, lifestyle, or environmental exposure, SMA develops because of inherited changes in specific genes. Parents who carry one altered copy of the SMN1 gene are called carriers. Carriers usually do not have symptoms because their second copy of the gene functions normally.
Many carriers never realize they have the altered gene until a child is diagnosed or genetic testing is performed.
This often surprises families because there may be no previous history of SMA. The altered gene can quietly pass through several generations before two carriers have a child together.
SMA usually follows an autosomal recessive inheritance pattern.
For a child to develop the condition, they typically inherit one non-working SMN1 gene from each parent.
If both parents are carriers, each pregnancy has the following possibilities:
Each pregnancy represents a new genetic event, meaning previous pregnancies do not change the probabilities for future children.
This inheritance pattern explains why healthy parents can unexpectedly have a child diagnosed with SMA.
Yes, and this is one of the most misunderstood aspects of the condition.
Many families assume that if no relatives have SMA, their children cannot be affected. However, carriers generally do not experience symptoms, making the condition difficult to recognize before genetic testing.
In some rare situations, a new genetic change may occur spontaneously rather than being inherited. These cases are uncommon, but they help explain why genetic conditions can occasionally appear without an obvious family pattern.
Common Misconception
No known family history does not automatically mean there is no inherited genetic risk.
One of the first questions many parents ask after a diagnosis is whether something during pregnancy caused the condition.
Current scientific evidence shows that typical activities during pregnancy—such as diet, exercise, stress, work, or everyday lifestyle choices—do not cause spinal muscular atrophy.
Because SMA is primarily linked to inherited genetic changes, it develops long before birth as the baby's genetic makeup is formed.
Understanding this distinction is important because many families experience unnecessary guilt after receiving a diagnosis. Learning that SMA is a genetic condition can help redirect conversations toward appropriate medical guidance rather than self-blame.
Engagement Check: If SMA is determined before birth through genetics, what role can genetic testing play before or during pregnancy? This question often becomes the next step for families planning future pregnancies.
Although the underlying genetic cause is similar, SMA does not affect everyone in the same way.
Several factors influence symptom severity, including:
Some people develop symptoms during infancy, while others may not notice muscle weakness until later childhood or adulthood.
Because symptom patterns vary, healthcare providers rely on genetic testing and clinical evaluation together rather than symptoms alone.
Doctors usually confirm SMA using genetic testing rather than relying solely on physical symptoms.
Testing may involve:
These tests help determine whether SMN1 gene changes are present and may also provide information about SMN2 copy numbers, which can offer additional insight into the condition.
For many families, understanding the genetic cause becomes the foundation for discussing future medical care, family planning, and available support resources.
Yes. Most carriers have no symptoms because one healthy copy of the SMN1 gene provides enough protein for normal motor neuron function. Many carriers discover their status only after family genetic testing.
Some forms of SMA appear during adulthood. In these cases, the underlying genetic changes are present from birth, but symptoms develop much later.
No. Spinal muscular atrophy cannot spread from one person to another. It is a genetic condition rather than an infectious disease.
If a child or close relative is diagnosed with SMA, healthcare providers may recommend genetic counseling and carrier testing for other family members to better understand inherited risk.
Yes. Carrier screening can determine whether someone carries an altered SMN1 gene, helping prospective parents better understand the likelihood of passing SMA to future children.
Typically, no. People with one working and one altered copy are usually healthy carriers without symptoms.
Many newborn screening programs now include SMA, allowing affected infants to be identified early. Availability depends on local screening policies.
Understanding what causes spinal muscular atrophy answers an important first question, but it naturally leads to others. Families often want to know how the condition is diagnosed, whether genetic testing is appropriate for relatives, how inheritance affects future pregnancies, and why symptoms differ from one person to another. As those questions emerge, comparing genetic testing options, learning about genetic counseling, and understanding available care pathways become logical next steps in making informed decisions.